IRVINE, Calif., Feb. 4, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced its Chairman, Marvin P. Loeb, was interviewed by Ian Roberts of the Wall Street Reporter. The audio interview is posted on the http://www.wallstreetreporter.com web site.
Mr. Loeb described Trimedyne's business, financial condition, its current laser products, new laser products it is developing and Trimedyne's strategy and goals for the future.
Commenting on the interview, Mr. Loeb said, "We are happy that Wall Street Reporter invited us to talk about Trimedyne. We are pleased by the increased attention being paid to Trimedyne's continued profitability, its new laser products and their market potential."
To access the audio interview, go to http://www.wallstreetreporter.com, log in and click on Trimedyne.
Trimedyne is a leading manufacturer of surgical lasers and proprietary fiber optic devices for use in a variety of minimally invasive surgical procedures, many of which are performed on an outpatient basis at substantially less cost than conventional surgery. For product, financial and other information, visit Trimedyne's website at http://www.trimedyne.com.
"Safe Harbor" Statement Under the Private Securities Litigation Reform Act:
Statements in this news release and the above mentioned interview may contain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1993 and Section 21E of the Securities and Exchange Act of 1934. Such statements may involve various risks and uncertainties, some of which may be discussed in the Company's most recent report on Form 10-K-SB and subsequently filed SEC reports. There is no assurance such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements.